What actually changed (and what didn’t)
It’s worth being precise, because the headlines blur together. Here is what is documented:
- EDE consolidation. The Emirates Drug Establishment assumed 44 core regulatory services from the Ministry of Health and Prevention — marketing authorisations, import/export permits, GMP certification, facility licensing — effective end of 2025.[1]
- DoH AI policy. Abu Dhabi’s DoH published its Policy on the Use of AI in the Healthcare Sector — the first emirate-level AI governance framework in the region — and introduced a Responsible AI Standard in 2025 with updated technical, data-privacy, transparency and explainability conditions for healthcare AI.[2]
- AI in licensure. The DoH is aligning licensure with the UAE’s national AI strategy, including a move toward computer-adaptive testing and building AI competency into the professional qualification framework.[2]
- Regulators using AI themselves. Saudi Arabia’s SFDA launched RASID — an AI service that verifies controlled medications carried by travellers, supporting 50+ languages — an example of AI moving into front-line drug regulation.[6]
What there is not (yet) is a single, separately-named “AI-literacy certificate” every pharmacist must hold. The direction is clear; the exact mechanism continues to evolve. Treat AI competence as an expected professional standard and confirm specifics with your licensing authority.
The 2026 GCC regulatory map for pharmacists
| Body | Level | Relevance to AI in pharmacy |
|---|---|---|
| EDE | UAE federal | Drug/device registration, licensing, GMP — 44 services from MOHAP (end-2025)[1] |
| DoH (Abu Dhabi) | Emirate | AI policy + Responsible AI Standard (2025); AI in licensure[2] |
| DHA (Dubai) | Emirate | Licensure and quality environment incorporating digital/AI |
| SFDA (KSA) | National | Drug regulation; RASID AI service for controlled-medication checks[6] |
| ISO/IEC 42001 · NIST AI RMF | Global backbone | AI management & risk frameworks regulators reference[4][5] |
What responsible AI use looks like for a pharmacist
- Use AI appropriately for clinical, operational, and patient-facing tasks.
- Verify output before acting — never treat a model’s answer as authoritative on its own.
- Understand the limits — hallucination, bias, data privacy, and where AI must not make the final call.
- Operate within governance — keep audit trails, respect patient-data rules, stay inside a defined framework.
- Stay accountable — the pharmacist, not the AI, owns every clinical decision.
Why this is an opportunity, not just a burden
Two pharmacists apply for the same senior role. One says “I use ChatGPT sometimes.” The other shows a governance self-audit, a redesigned workflow with measured results, and a portfolio case study built inside the exact frameworks regulators reference. The shift toward AI competence didn’t hold the second pharmacist back — it handed them a way to stand out.
Frequently asked questions
Is there a single “DoH AI-literacy mandate” I must comply with?
Not as one named rule. AI competence is being built into UAE healthcare practice through several instruments — the DoH AI policy and 2025 Responsible AI Standard, EDE consolidation, and AI in licensure.[2] Confirm specifics with your licensing authority.
What frameworks should a UAE pharmacy follow?
ISO/IEC 42001 (2023) and NIST AI RMF (2023) as the global backbone, mapped to local requirements like the DoH AI policy and Abu Dhabi Responsible AI Standard.[4][5][2]
What is SFDA RASID?
RASID is an AI service from Saudi Arabia’s SFDA that verifies controlled medications carried by travellers in 50+ languages — not a general pharmacy-licensing system.[6]
Benchmark yourself first
The free AI-Native Pharmacist Scorecard shows where you stand against this changing landscape in 2 minutes.
References
- Ministry of Health and Prevention (UAE), transfer of key services to the Emirates Drug Establishment (44 services, effective end-2025). mohap.gov.ae; Arabian Business.
- International Bar Association, “How is AI in healthcare being regulated in the UAE?” (DoH AI policy, 2025 Responsible AI Standard, AI in licensure). ibanet.org.
- NIST, “AI Risk Management Framework (AI RMF 1.0),” 2023. nist.gov.
- ISO/IEC 42001:2023, “Artificial intelligence — Management system.” iso.org.
- Saudi Food and Drug Authority, “RASID smart service for verifying controlled medications.” sfda.gov.sa; GCC Business News.
This article is educational and does not constitute legal or regulatory advice. Regulations evolve — always confirm current requirements directly with the EDE, DoH, DHA, or SFDA.
Ready to become an AI-native pharmacist? The AI-Native Pharmacist Stack course turns this into hands-on capability — 30 interactive lessons, self-paced, built for the GCC and beyond.